The U.S. Environmental Protection Agency (EPA) and Department of Health and Human Services (HHS) announced that they are moving forward with new microplastic regulations. This action highlights a growing federal effort to better understand and address microplastics. Microplastics can be found in water, food and even the air. Federal agencies are now combining research and regulatory review to evaluate potential health risks and future regulatory standards. New efforts represent a more coordinated federal approach to emerging contaminants. If new standards are adopted, states and regulated entities may need to implement new testing and treatment processes. At the same time, innovation in detection and removal technologies could create new opportunities in healthcare and environmental management. This shift could impact public health systems, water providers and manufacturers.
Key Federal Actions
- ARPA-H Research Initiative: The Advanced Research Projects Agency for Health is funding research into new ways to find and potentially remove microplastics from the human body. This includes developing tools to detect these particles and studying how they may affect human health over time.
- EPA Drinking Water Review: The Environmental Protection Agency has opened a public comment period to update the Drinking Water Contaminant Candidate List, which is a list of substances that may need to be regulated in drinking water. Microplastics and certain drug residues are among the emerging concerns that the EPA is looking to regulate in drinking water. Comments can be submitted here. Comments are due by June 5, 2026 at 11:59 PM EDT.
Policy and Regulatory Context
Federal agencies are increasingly viewing microplastics as both an environmental and public health issue. The EPA’s review process could lead to future rules requiring testing or treatment.
At the same time, ARPA-H’s work signals a broader approach. In addition to preventing exposure, federal efforts are beginning to explore how to address microplastics that may already be present in the body.
Stakeholder Perspectives
Federal officials have framed the action as a proactive step grounded in public health concerns. EPA Administrator Lee Zeldin stated that the agency will “follow the science” in addressing emerging contaminants, while HHS Secretary Robert F. Kennedy Jr. emphasized a coordinated federal response to microplastics as a potential health risk. Public health and environmental advocates have offered mixed reactions, with some researchers describing the effort as an important first step toward understanding exposure risks, while others have questioned whether the action will lead to enforceable standards. Industry stakeholders have generally supported continued research but urged caution on regulation, with the Plastics Industry Association calling for science-based thresholds before new requirements are imposed.
FOCUS will continue to monitor developments on microplastics policy across the country.
by Juliana Walsh 4/13/26
